Skip to main content
Tata Chemicals Ltd logo

Tata Chemicals Ltd — Investor Relations & Filings

Ticker · TATACHEM ISIN · INE092A01019 LEI · 335800H6MURUA6FBOW17 BSE.NS Manufacturing
Open in API
Filings indexed 2,734 across all filing types
Latest filing 2025-07-25 Regulatory Filings
Country IN India
Listing BSE.NS TATACHEM

About Tata Chemicals Ltd

https://www.tatachemicals.com/

Tata Chemicals Ltd provides chemistry-led solutions through its Basic Chemistry and Specialty Products segments. It is a leading global producer of soda ash and sodium bicarbonate, serving sectors such as glass, detergents, pharmaceuticals, and food processing. The specialty portfolio includes agro sciences, nutritional sciences, and material sciences, with a focus on prebiotics, highly dispersible silica, and crop protection through its subsidiary, Rallis India. The company operates manufacturing facilities across four continents and invests in energy sciences, specifically lithium-ion battery materials. Its operations are characterized by innovation-driven R&D and sustainable manufacturing practices. By integrating science with sustainability, the company delivers essential ingredients and specialized solutions to a global customer base across industrial and agricultural markets.

Recent filings

Filing Released Lang Actions
Adoption of revised Code of Corporate Disclosure Practices and Policy on determination of Legitimate Purpose
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the adoption of a revised Code of Corporate Disclosure Practices and a Policy on determination of Legitimate Purpose. It references compliance with a regulatory requirement (SEBI Prohibition of Insider Trading Regulations) and states that the revised code and policy are available on the company's website. The document is short (1206 characters) and serves as an announcement of the adoption of governance-related policies rather than the policies themselves or a detailed governance report. It does not contain financial data, audit information, or detailed management discussion. It is not a report but an announcement to take the revised code on record. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-07-25 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the adoption of a revised Code of Corporate Disclosure Practices and a Policy on determination of Legitimate Purpose. It references compliance with a regulatory requirement (SEBI Prohibition of Insider Trading Regulations) and states that the revised code is available on the company's website. The document is short (1206 characters) and serves as an announcement of a corporate governance policy update rather than the policy document itself or a detailed governance report. It does not contain financial data, management discussion, or detailed governance structures. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-07-25 English
Pursuant to Regulations 30, 33, 51 and 52 and other applicable Regulations of the SEBI Listing Regulations, we wish to inform you that the Board of Directors at their Meeting held today ....
Regulatory Filings
2025-07-25 English
Outcome of Board Meeting
Regulatory Filings
2025-07-25 English
Outcome of the Board Meeting dated July 25, 2025
Regulatory Filings
2025-07-25 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.